Immediate Impact
3 by Nobel laureates 4 from Science/Nature 65 standout
Citing Papers
Renal cell carcinoma
2024 Standout
Perioperative Pembrolizumab for Early-Stage Non–Small-Cell Lung Cancer
2023 Standout
Works of Mark R. Olsen being referenced
PointBreak: A Randomized Phase III Study of Pemetrexed Plus Carboplatin and Bevacizumab Followed by Maintenance Pemetrexed and Bevacizumab Versus Paclitaxel Plus Carboplatin and Bevacizumab Followed by Maintenance Bevacizumab in Patients With Stage IIIB or IV Nonsquamous Non–Small-Cell Lung Cancer
2013
Randomized Phase II Trial of Sunitinib on an Intermittent Versus Continuous Dosing Schedule As First-Line Therapy for Advanced Renal Cell Carcinoma
2012
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Mark R. Olsen | 579 | 410 | 254 | 20 | 757 | |
| Ursula Vogl | 410 | 392 | 336 | 20 | 864 | |
| Kristina Lamberg | 412 | 402 | 191 | 20 | 762 | |
| Sven Gogov | 399 | 335 | 287 | 25 | 768 | |
| H. Depenbrock | 491 | 569 | 234 | 33 | 923 | |
| Tim Eisen | 602 | 296 | 524 | 29 | 883 | |
| Ilaria Imarisio | 459 | 306 | 332 | 37 | 908 | |
| Erin Larkins | 418 | 608 | 271 | 26 | 881 | |
| Robin Wiltshire | 702 | 546 | 284 | 17 | 803 | |
| Daniel Lee | 587 | 484 | 185 | 34 | 794 | |
| Joyce Cheng | 354 | 570 | 231 | 28 | 893 |
All Works
Loading papers...